Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Oral Option
.
Show all posts
Showing posts with label
Oral Option
.
Show all posts
Friday, October 30, 2026
FDA Approves Xocova (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure
›
In continuation of my update on ensitrelvir Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, P...
›
Home
View web version
